1[1]Wilkins MR, Redondo J, Brown LA. The natriuretic peptide family.Lancet, 1997,349 : 1307 - 1310
2[2]Luchner A, Stevens TL, Borgeson DD, et al. Different atrial and ventriculur expression of myocardial BNP during evolution of heart failure.46th Annual Scientific Session of America College of Cardiology, 1998,H1684 - H1689
3[3]Mair J, Lercher AH, Puschendort B. The impact of cardiac natriuretic peptides determination on the diagnosis and management of heart failure.Clin Chem Lab, 2001,39(7) 571 -588
4[4]Stingo AJ, Clavell AL, Heublein DM, et al. Presence ofC - type natriuretic peptides in cultured human endothelial cells and plasma. Am J Physiol, 1992, 235:561 - 576
5[5]Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptide are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol, 2001,12:1508- 1515
6[6]Kohs KP, Feifel K, Mayer Wehrstain R. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. Clin Nephrol,1993,40:83 - 90
7[7]McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptonmatic left vantricular systolic dysfunction in an urban population.Lancet, 1997, 350: 829 - 833
8[8]Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substady of the studies of left veatricular dysfunction (SOLVD). Circulation, 1990, 82:1724 - 1729
9[9]Struthers. Prospects for using a blood sample in the diagnosis of heart failure Q J Med, 1995, 88:303 - 306
10[10]Maeda K, Tsutamoto T, Wada A, et al. High levels of plasma brain natriuretic peptide and interleukin - 6 after optimized treatment for heart failure arc independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coil Cardiol, 2000,36:1587- 93
